Navigation Links
Solving the riddle of nature's perfect spring
Date:3/1/2011

Scientists have unravelled the shape of the protein that gives human tissues their elastic properties in what could lead to the development of new synthetic elastic polymers.

University of Manchester researchers, working with colleagues in Australia and the United States, used state-of-the-art techniques to reveal the structure of tropoelastin, the main component of elastin.

Elastin allows tissues in humans and other mammals to stretch, for example when the lungs expand and contract for respiration or when arteries widen and narrow over the course of a billion heart beats.

The study, published in the science journal PNAS (March issue), revealed how evolution has triumphed where engineering has so far failed by generating a molecule with near-perfect elasticity that will last a lifetime.

"All mammals rely on elastin to provide their tissues with the ability to stretch and then return to their original shape," said researcher Dr Clair Baldock, from the University of Manchester's Wellcome Trust Centre for Cell Matrix Research. "This high level of physical performance demanded of elastin vastly exceeds and indeed outlasts all human-made elastics.

"It is the co-ordinated assembly of many tropoelastins into elastin that gives tissues their stretchy properties and this exquisite assembly helps to generate elastic tissues as diverse as artery, lung and skin.

"We discovered that tropoelastin is a curved, spring-like molecule with a 'foot' region to facilitate attachment to cells. Stretching and relaxing experiments showed that the molecule had the extraordinary capacity to extend to eight-times its initial length and can then return to its original shape with no loss of energy, making it a near-perfect spring."

She added: "Elastics are used in applications as diverse as clothing, vehicles, tissue engineering and even space travel, so understanding how the structure of tropoelastin creates its exceptional elastic properties will hopefully enable the development of synthetic 'elastin-like' polymers with potentially wide-ranging applications and benefits."

Initiator and research project leader Tony Weiss, Professor in the School of Molecular Bioscience, The University of Sydney, added: "Tropoelastin is a tiny protein 'nanospring' in the human body. Our bodies assemble these nanosprings to put elasticity into tissues like skin, blood vessels and lung.

"Our finding is the result of more than a decade of international collaboration. Our scientific teamwork spans Australia, the UK, USA and Europe. Tropoelastin's extraordinary capacity to extend to eight-times its initial length and then return to its original shape, with no loss of energy, is nature showing us how to make an ideal nanospring."


'/>"/>

Contact: Aeron Haworth
aeron.haworth@manchester.ac.uk
44-161-275-8383
University of Manchester
Source:Eurekalert

Related biology news :

1. Bowman Global Change says public engagement critical to solving climate crisis
2. Brains problem-solving function at work when we daydream
3. Solving the puzzle of the BK ion channel
4. Toward resolving Darwins abominable mystery
5. TriCipher myOneLogin SignatureBook Offers Digital Signatures On-Demand
6. Genetic signatures provide new direction in liver cancer
7. Beverages leave geographic signatures that can track peoples movements
8. Genome signatures enable tracking of algal complexity
9. Blood signatures to diagnose infection
10. CIC Announces Upcoming Webinar: Insurance Consumer Expectations; Customer Experience & Self-Service Will Hit New Highs in 2011! The Role eSignatures Will Play in Meeting that Demand
11. Study identifies new genetic signatures of breast cancer drug resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):
(Date:7/26/2017)... Jacksonville, FL (PRWEB) , ... July 26, 2017 ... ... deep learning algorithms targeted towards leveraging the years of diagnostic excellence by Mayo ... Logix. The first product suite will be distributed through the Microsoft Azure ...
(Date:7/25/2017)... Chestertown, Maryland (PRWEB) , ... ... ... is pleased to welcome Chuck Heinz as Executive Director of Strategic ... asset to the Benchworks team. , Chuck’s professional experience encompasses marketing and ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... stock market news outlet had initiated coverage on Interpace Diagnostics. Interpace Diagnostics ... identifies exposure, progression and risk analysis from specific cancers in humans. , ...
(Date:7/20/2017)... ... ... VIC Technology Venture Development™ (VIC™), is pleased to announce that James ... to strengthen and diversify VIC’s board. , "We are excited to have Jamie join ... business executive with a broad range of experience directly relevant to VIC as we ...
Breaking Biology Technology: